1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: DECEMBER 21, 2000
COLORADO MEDTECH, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
COLORADO 000-12471 84-0731006
- ---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File I.R.S. Employer
of incorporation) Number) Identification No.)
6175 LONGBOW DRIVE
BOULDER, COLORADO 80301
-------------------------------------------------------------
(Address, including zip code, of principal executive offices)
(303) 530-2660
-------------------------------
(Registrant's telephone number,
including area code)
2
ITEM 5. OTHER EVENTS.
Colorado MEDtech, Inc. issued a press release regarding its expected
second quarter results. The text of the press release is attached hereto as
Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENT AND EXHIBITS.
(c) Exhibits.
No. Description
--- -----------
99.1 Press release dated December 21, 2000
-2-
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATED, this 21st day of December, 2000.
COLORADO MEDTECH, INC.
By: /s/ Stephen K. Onody
---------------------------------
Stephen K. Onody
Chief Executive Officer
-3-
4
EXHIBIT INDEX
No. Description
--- -----------
99.1 Press release dated December 21, 2000